mk-0752
Small moleculeexperimental
Clinical trial activity
9 trials · 12 clinical orgs · 0 marketing orgs
Phase 1
8
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2005 (NCT00100152)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
- Brain Neoplasms · Phase 1
- Breast Neoplasms · Phase 1/Phase 2
- Healthy Volunteers · Phase 1
- Leukemia, Lymphocytic, Chronic, B-Cell · Phase 1
- Leukemia, Myeloid · Phase 1
- Myelodysplastic Syndromes · Phase 1
- Neoplasms · Phase 1
- Pancreatic Neoplasms · Phase 1
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma · Phase 1
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
O=C(O)CC[C@H]1CC[C@@](c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1- Mol. weight
- 442.91 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4205422 ↗
Also known as
- 3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid
- mk0752
- mk0752
- mk0752
- mk 0752
- mk-0752
- mk-0752
- mk-0752
- mk-0752
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01295632 | Phase 1 | Feb 1, 2011 | Merck |
| NCT01243762 | Phase 1 | Nov 1, 2010 | Merck |
| NCT01098344 | Phase 1 | Apr 1, 2010 | Cancer Research UK, University of Cambridge |
| NCT00803894 | Phase 1 | Dec 1, 2008 | Merck |
| NCT00572182 | Phase 1 | Jul 1, 2008 | National Cancer Institute (NCI), Pediatric Brain Tumor Consortium, University of Cincinnati |
| NCT00756717 | N/A | May 1, 2008 | Loyola University, Merck |
| NCT00645333 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2008 | Baylor University, Cornell University, Harvard University, Merck, Ohio State University, University of Michigan |
| NCT00106145 | Phase 1 | Apr 1, 2005 | Merck |
| NCT00100152 | Phase 1 | Feb 1, 2005 | Merck |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (12)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 7 | 5 | 3 | 2005 |
| Baylor University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Cancer Research UK | Academic/Hospital | 1 | 1 | 1 | 2010 |
| Cornell University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Loyola University | Academic/Hospital | 1 | 1 | 1 | 2008 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2008 |
| Ohio State University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Pediatric Brain Tumor Consortium | Academic/Hospital | 1 | 1 | 1 | 2008 |
| University of Cambridge | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Cincinnati | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Michigan | Academic/Hospital | 1 | 1 | 1 | 2008 |
12 organizations
Page 1 / 1